The Scientific Advisors at Caraway Therapeutics play a crucial role in guiding the company’s research and development strategy by providing expert insights on genetic data and biological processes. They leverage their expertise to inform the design of proprietary small molecules, ensuring that the therapeutic approach effectively accelerates the clearance of toxic materials and enhances cellular function. Collectively, they contribute to advancing innovative solutions in the field of cellular health and therapeutic development.
Amy Ripka
Scientific Advisor
Bernardo Sabatini
Scientific Advisor
David E. Clapham
Scientific Advisor
Ivan Dikic
Co-Founder & Scientific Adviso...
James B. Summers
Scientific Advisor
John Lowe
Scientific Advisor
John McCall
Scientific Advisor
Kalpana Merchant
Scientific Advisor
Tim Harris
Chair, Scientific Advisory Boa...
Wade Harper
Co-Founder & Scientific Adviso...
View all